Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase.
The report details the trend, potential and market size of Postmenopausal Vaginal Atrophy Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Postmenopausal Vaginal Atrophy Treatmentmarket, defines the market attractiveness level of Postmenopausal Vaginal Atrophy Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Postmenopausal Vaginal Atrophy Treatment industry, describes the types of Postmenopausal Vaginal Atrophy Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Postmenopausal Vaginal Atrophy Treatment market and the development prospects and opportunities of Postmenopausal Vaginal Atrophy Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Postmenopausal Vaginal Atrophy Treatment market in Chapter 13.
By Player:
Shionogi
Novo Nordisk
Pfizer
Teva Pharmaceutical
Allergan
By Type:
Creams
Tablets
Patches
Rings
By End-User:
Topical Estrogen
Systemic Estrogen
Non-hormonal
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Postmenopausal Vaginal Atrophy Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Postmenopausal Vaginal Atrophy Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Postmenopausal Vaginal Atrophy Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Postmenopausal Vaginal Atrophy Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Postmenopausal Vaginal Atrophy Treatment Market Analysis and Outlook to 2022
-
7.1 Global Postmenopausal Vaginal Atrophy Treatment Consumption (2017-2022)
-
7.2 United States Postmenopausal Vaginal Atrophy Treatment Consumption (2017-2022)
-
7.3 Europe Postmenopausal Vaginal Atrophy Treatment Consumption (2017-2022)
-
7.4 China Postmenopausal Vaginal Atrophy Treatment Consumption (2017-2022)
-
7.5 Japan Postmenopausal Vaginal Atrophy Treatment Consumption (2017-2022)
-
7.6 India Postmenopausal Vaginal Atrophy Treatment Consumption (2017-2022)
-
7.7 South Korea Postmenopausal Vaginal Atrophy Treatment Consumption (2017-2022)
8 Region and Country-wise Postmenopausal Vaginal Atrophy Treatment Market Analysis and Outlook to 2028
-
8.1 Global Postmenopausal Vaginal Atrophy Treatment Consumption Forecast (2022-2028)
-
8.2 United States Postmenopausal Vaginal Atrophy Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Postmenopausal Vaginal Atrophy Treatment Consumption Forecast (2022-2028)
-
8.4 China Postmenopausal Vaginal Atrophy Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Postmenopausal Vaginal Atrophy Treatment Consumption Forecast (2022-2028)
-
8.6 India Postmenopausal Vaginal Atrophy Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Postmenopausal Vaginal Atrophy Treatment Consumption Forecast (2022-2028)
9 Global Postmenopausal Vaginal Atrophy Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Postmenopausal Vaginal Atrophy Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Creams Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Tablets Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Patches Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Rings Consumption and Growth Rate (2017-2022)
-
9.2 Global Postmenopausal Vaginal Atrophy Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Topical Estrogen Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Systemic Estrogen Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Non-hormonal Consumption and Growth Rate (2017-2022)
10 Global Postmenopausal Vaginal Atrophy Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Postmenopausal Vaginal Atrophy Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Creams Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Patches Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Rings Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Postmenopausal Vaginal Atrophy Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Topical Estrogen Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Systemic Estrogen Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Non-hormonal Consumption Forecast and Growth Rate (2022-2028)
11 Global Postmenopausal Vaginal Atrophy Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Postmenopausal Vaginal Atrophy Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Postmenopausal Vaginal Atrophy Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Postmenopausal Vaginal Atrophy Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Postmenopausal Vaginal Atrophy Treatment Market Competitive Analysis
-
14.1 Shionogi
-
14.1.1 Shionogi Company Details
-
14.1.2 Shionogi Postmenopausal Vaginal Atrophy Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Shionogi Postmenopausal Vaginal Atrophy Treatment Product and Service
-
14.2 Novo Nordisk
-
14.2.1 Novo Nordisk Company Details
-
14.2.2 Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Postmenopausal Vaginal Atrophy Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Postmenopausal Vaginal Atrophy Treatment Product and Service
-
14.4 Teva Pharmaceutical
-
14.4.1 Teva Pharmaceutical Company Details
-
14.4.2 Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Product and Service
-
14.5 Allergan
-
14.5.1 Allergan Company Details
-
14.5.2 Allergan Postmenopausal Vaginal Atrophy Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Allergan Postmenopausal Vaginal Atrophy Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Postmenopausal Vaginal Atrophy Treatment
-
Figure Postmenopausal Vaginal Atrophy Treatment Picture
-
Table Global Postmenopausal Vaginal Atrophy Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Postmenopausal Vaginal Atrophy Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Postmenopausal Vaginal Atrophy Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Postmenopausal Vaginal Atrophy Treatment Consumption by Country (2017-2022)
-
Figure United States Postmenopausal Vaginal Atrophy Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Postmenopausal Vaginal Atrophy Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Postmenopausal Vaginal Atrophy Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Postmenopausal Vaginal Atrophy Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Postmenopausal Vaginal Atrophy Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Postmenopausal Vaginal Atrophy Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Postmenopausal Vaginal Atrophy Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Postmenopausal Vaginal Atrophy Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Postmenopausal Vaginal Atrophy Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Postmenopausal Vaginal Atrophy Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Postmenopausal Vaginal Atrophy Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Postmenopausal Vaginal Atrophy Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Postmenopausal Vaginal Atrophy Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Creams Consumption and Growth Rate (2017-2022)
-
Figure Global Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Patches Consumption and Growth Rate (2017-2022)
-
Figure Global Rings Consumption and Growth Rate (2017-2022)
-
Figure Global Topical Estrogen Consumption and Growth Rate (2017-2022)
-
Figure Global Systemic Estrogen Consumption and Growth Rate (2017-2022)
-
Figure Global Non-hormonal Consumption and Growth Rate (2017-2022)
-
Figure Global Creams Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Patches Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rings Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Topical Estrogen Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Systemic Estrogen Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-hormonal Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Postmenopausal Vaginal Atrophy Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Postmenopausal Vaginal Atrophy Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Shionogi (Foundation Year, Company Profile and etc.)
-
Table Shionogi Postmenopausal Vaginal Atrophy Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shionogi Postmenopausal Vaginal Atrophy Treatment Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Postmenopausal Vaginal Atrophy Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Postmenopausal Vaginal Atrophy Treatment Product and Service
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Postmenopausal Vaginal Atrophy Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Postmenopausal Vaginal Atrophy Treatment Product and Service
-
